Search Results
ANGLE announce first large-scale pharma services contract for Parsortix liquid biopsy
ANGLE PLC submits its flagship Parsortix liquid biopsy diagnostic to the FDA
ANGLE completes FDA submission for Parsortix system for metastatic breast cancer
ANGLE PLC's Andrew Newland on 'very exciting' liquid biopsy breakthrough
ANGLE PLC – a small British company changing the world in cancer
ANGLE PLC: Proactive One2One Virtual Conference
Andrew Newland, Chief Executive of ANGLE (AGL)
ANGLE PLC sees big opportunities in non-invasive prenatal testing
ANGLE (AGL) - Andrew Newland, Chief Executive & Ian Griffiths, FD
ANGLE Parsortix Procedure
ANGLE plc (AGL) - Andrew Newland, CEO and Ian Griffiths, CFO
ANGLE CEO says latest cancer results "may turn out to be groundbreaking"
